| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CVS - CVS Health Corp | HOLD | 0 @ USD 66.68 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 66.68. The average price that CVS shares were previous bought at was USD 63.5284. The current market price is 5.0% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 442,312 compared to the previous valuation of CVS Health Corp |
| DVA - DaVita HealthCare Partners Inc | SELL | -46 @ USD 142.81 | USD -6,569 | The ETF sold 46 shares of DVA on 2025-07-07. The shares were previously bought for an average price of USD 152.044. The DaVita HealthCare Partners Inc shares were sold for -6.1% lower than average price of previous purchases. This resulted in an overall loss of USD 425 The average price that the ETF previously sold DVA share for is USD 147.959 which is higher than the selling price of USD 142.81 on 2025-07-07. |
| CRL - Creightons Plc | SELL | -54 @ USD 153.9 | USD -8,311 | The ETF sold 54 shares of CRL on 2025-07-07. The shares were previously bought for an average price of USD 166.023. The Creightons Plc shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 655 The average price that the ETF previously sold CRL share for is USD 175.631 which is higher than the selling price of USD 153.9 on 2025-07-07. |
| TECH - Bio-Techne Corp | SELL | -172 @ USD 51.535 | USD -8,864 | The ETF sold 172 shares of TECH on 2025-07-07. The shares were previously bought for an average price of USD 62.9582. The Bio-Techne Corp shares were sold for -18.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,965 The average price that the ETF previously sold TECH share for is USD 67.4931 which is higher than the selling price of USD 51.535 on 2025-07-07. |
| HSIC - Henry Schein Inc | SELL | -138 @ USD 73.45 | USD -10,136 | The ETF sold 138 shares of HSIC on 2025-07-07. The shares were previously bought for an average price of USD 72.5313. The Henry Schein Inc shares were sold for 1.3% higher than average price of previous purchases. This sale made a profit of USD 127 The average price that the ETF previously sold HSIC share for is USD 71.2482 so the ETF has sold 138 shares on 2025-07-07 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -368 @ USD 29.9 | USD -11,003 | The ETF sold 368 shares of MRNA on 2025-07-07. The shares were previously bought for an average price of USD 34.1169. The Moderna Inc shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,552 The average price that the ETF previously sold MRNA share for is USD 39.3778 which is higher than the selling price of USD 29.9 on 2025-07-07. |
| UHS - Universal Health Services Inc | SELL | -62 @ USD 181.52 | USD -11,254 | The ETF sold 62 shares of UHS on 2025-07-07. The shares were previously bought for an average price of USD 186.901. The Universal Health Services Inc shares were sold for -2.9% lower than average price of previous purchases. This resulted in an overall loss of USD 334 The average price that the ETF previously sold UHS share for is USD 190.31 which is higher than the selling price of USD 181.52 on 2025-07-07. |
| SOLV - Solventum Corp. | SELL | -154 @ USD 76.24 | USD -11,741 | The ETF sold 154 shares of SOLV on 2025-07-07. The shares were previously bought for an average price of USD 73.9165. The Solventum Corp. shares were sold for 3.1% higher than average price of previous purchases. This sale made a profit of USD 358 The average price that the ETF previously sold SOLV share for is USD 70.8845 so the ETF has sold 154 shares on 2025-07-07 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -178 @ USD 67.27 | USD -11,974 | The ETF sold 178 shares of INCY on 2025-07-07. The shares were previously bought for an average price of USD 68.9686. The Incyte Corporation shares were sold for -2.5% lower than average price of previous purchases. This resulted in an overall loss of USD 302 The average price that the ETF previously sold INCY share for is USD 71.8649 which is higher than the selling price of USD 67.27 on 2025-07-07. |
| VTRS - Viatris Inc | SELL | -1,334 @ USD 9.2 | USD -12,273 | The ETF sold 1334 shares of VTRS on 2025-07-07. The shares were previously bought for an average price of USD 10.2249. The Viatris Inc shares were sold for -10.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,367 The average price that the ETF previously sold VTRS share for is USD 11.6243 which is higher than the selling price of USD 9.2 on 2025-07-07. |
| RVTY - Revvity Inc. | SELL | -130 @ USD 98.71 | USD -12,832 | The ETF sold 130 shares of RVTY on 2025-07-07. The shares were previously bought for an average price of USD 110.032. The Revvity Inc. shares were sold for -10.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,472 The average price that the ETF previously sold RVTY share for is USD 109.46 which is higher than the selling price of USD 98.71 on 2025-07-07. |
| MOH - MOH | SELL | -60 @ USD 232.61 | USD -13,957 | The ETF sold 60 shares of MOH on 2025-07-07. The shares were previously bought for an average price of USD 306.545. The MOH shares were sold for -24.1% lower than average price of previous purchases. This resulted in an overall loss of USD 4,436 The average price that the ETF previously sold MOH share for is USD 305.492 which is higher than the selling price of USD 232.61 on 2025-07-07. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -60 @ USD 232.61 | USD -13,957 | The ETF sold 60 shares of MOH on 2025-07-07. The shares were previously bought for an average price of USD 306.545. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -24.1% lower than average price of previous purchases. This resulted in an overall loss of USD 4,436 The average price that the ETF previously sold MOH share for is USD 305.492 which is higher than the selling price of USD 232.61 on 2025-07-07. |
| ALGN - Align Technology Inc | SELL | -74 @ USD 193.83 | USD -14,343 | The ETF sold 74 shares of ALGN on 2025-07-07. The shares were previously bought for an average price of USD 187.06. The Align Technology Inc shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of USD 501 The average price that the ETF previously sold ALGN share for is USD 206.617 which is higher than the selling price of USD 193.83 on 2025-07-07. |
| HOLX - Hologic Inc | SELL | -248 @ USD 64.37 | USD -15,964 | The ETF sold 248 shares of HOLX on 2025-07-07. The shares were previously bought for an average price of USD 66.5861. The Hologic Inc shares were sold for -3.3% lower than average price of previous purchases. This resulted in an overall loss of USD 550 The average price that the ETF previously sold HOLX share for is USD 71.0567 which is higher than the selling price of USD 64.37 on 2025-07-07. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -222 @ USD 73.29 | USD -16,270 | The ETF sold 222 shares of COO on 2025-07-07. The shares were previously bought for an average price of USD 86.8441. The The Cooper Companies, Inc. Common Stock shares were sold for -15.6% lower than average price of previous purchases. This resulted in an overall loss of USD 3,009 The average price that the ETF previously sold COO share for is USD 92.3381 which is higher than the selling price of USD 73.29 on 2025-07-07. |
| BAX - Baxter International Inc | SELL | -574 @ USD 29.69 | USD -17,042 | The ETF sold 574 shares of BAX on 2025-07-07. The shares were previously bought for an average price of USD 32.4244. The Baxter International Inc shares were sold for -8.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,570 The average price that the ETF previously sold BAX share for is USD 32.1835 which is higher than the selling price of USD 29.69 on 2025-07-07. |
| WST - West Pharmaceutical Services Inc | SELL | -78 @ USD 221.48 | USD -17,275 | The ETF sold 78 shares of WST on 2025-07-07. The shares were previously bought for an average price of USD 251.218. The West Pharmaceutical Services Inc shares were sold for -11.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,320 The average price that the ETF previously sold WST share for is USD 291.761 which is higher than the selling price of USD 221.48 on 2025-07-07. |
| CNC - Concurrent Technologies Plc | SELL | -552 @ USD 33.05 | USD -18,244 | The ETF sold 552 shares of CNC on 2025-07-07. The shares were previously bought for an average price of USD 59.2099. The Concurrent Technologies Plc shares were sold for -44.2% lower than average price of previous purchases. This resulted in an overall loss of USD 14,440 The average price that the ETF previously sold CNC share for is USD 59.455 which is higher than the selling price of USD 33.05 on 2025-07-07. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -218 @ USD 92.57 | USD -20,180 | The ETF sold 218 shares of ZBH on 2025-07-07. The shares were previously bought for an average price of USD 104.881. The Zimmer Biomet Holdings Inc shares were sold for -11.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,684 The average price that the ETF previously sold ZBH share for is USD 105.286 which is higher than the selling price of USD 92.57 on 2025-07-07. |
| BIIB - Biogen Inc | SELL | -162 @ USD 130.13 | USD -21,081 | The ETF sold 162 shares of BIIB on 2025-07-07. The shares were previously bought for an average price of USD 141.02. The Biogen Inc shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,764 The average price that the ETF previously sold BIIB share for is USD 153.368 which is higher than the selling price of USD 130.13 on 2025-07-07. |
| DGX - Quest Diagnostics Incorporated | SELL | -124 @ USD 173.97 | USD -21,572 | The ETF sold 124 shares of DGX on 2025-07-07. The shares were previously bought for an average price of USD 168.441. The Quest Diagnostics Incorporated shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of USD 686 The average price that the ETF previously sold DGX share for is USD 162.601 so the ETF has sold 124 shares on 2025-07-07 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -64 @ USD 346.73 | USD -22,191 | The ETF sold 64 shares of WAT on 2025-07-07. The shares were previously bought for an average price of USD 362.82. The Waters Corporation shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,030 The average price that the ETF previously sold WAT share for is USD 368.76 which is higher than the selling price of USD 346.73 on 2025-07-07. |
| WAT - MULETFWATIMETFP | SELL | -64 @ USD 346.73 | USD -22,191 | The ETF sold 64 shares of WAT on 2025-07-07. The shares were previously bought for an average price of USD 362.82. The MULETFWATIMETFP shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,030 The average price that the ETF previously sold WAT share for is USD 368.76 which is higher than the selling price of USD 346.73 on 2025-07-07. |
| PODD - Insulet Corporation | SELL | -76 @ USD 300.7 | USD -22,853 | The ETF sold 76 shares of PODD on 2025-07-07. The shares were previously bought for an average price of USD 277.376. The Insulet Corporation shares were sold for 8.4% higher than average price of previous purchases. This sale made a profit of USD 1,773 The average price that the ETF previously sold PODD share for is USD 269.572 so the ETF has sold 76 shares on 2025-07-07 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -92 @ USD 257.87 | USD -23,724 | The ETF sold 92 shares of LH on 2025-07-07. The shares were previously bought for an average price of USD 246.13. The Laboratory Corporation of America Holdings shares were sold for 4.8% higher than average price of previous purchases. This sale made a profit of USD 1,080 The average price that the ETF previously sold LH share for is USD 239.377 so the ETF has sold 92 shares on 2025-07-07 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -110 @ USD 233.32 | USD -25,665 | The ETF sold 110 shares of STE on 2025-07-07. The shares were previously bought for an average price of USD 223.954. The STERIS plc shares were sold for 4.2% higher than average price of previous purchases. This sale made a profit of USD 1,030 The average price that the ETF previously sold STE share for is USD 219.385 so the ETF has sold 110 shares on 2025-07-07 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -22 @ USD 1188.54 | USD -26,148 | The ETF sold 22 shares of MTD on 2025-07-07. The shares were previously bought for an average price of USD 1228.19. The Mettler-Toledo International Inc shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of USD 872 The average price that the ETF previously sold MTD share for is USD 1229.98 which is higher than the selling price of USD 1188.54 on 2025-07-07. |
| MTD - AMUNDI EUR GOV 710 | SELL | -22 @ USD 1188.54 | USD -26,148 | The ETF sold 22 shares of MTD on 2025-07-07. The shares were previously bought for an average price of USD 1228.19. The AMUNDI EUR GOV 710 shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of USD 872 The average price that the ETF previously sold MTD share for is USD 1229.98 which is higher than the selling price of USD 1188.54 on 2025-07-07. |
| IQV - IQVIA Holdings Inc | SELL | -180 @ USD 162.45 | USD -29,241 | The ETF sold 180 shares of IQV on 2025-07-07. The shares were previously bought for an average price of USD 186.439. The IQVIA Holdings Inc shares were sold for -12.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,318 The average price that the ETF previously sold IQV share for is USD 189.493 which is higher than the selling price of USD 162.45 on 2025-07-07. |
| HUM - Hummingbird Resources PLC | SELL | -134 @ USD 237.21 | USD -31,786 | The ETF sold 134 shares of HUM on 2025-07-07. The shares were previously bought for an average price of USD 263.605. The Hummingbird Resources PLC shares were sold for -10.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,537 The average price that the ETF previously sold HUM share for is USD 271.417 which is higher than the selling price of USD 237.21 on 2025-07-07. |
| HUM - Humana Inc | SELL | -134 @ USD 237.21 | USD -31,786 | The ETF sold 134 shares of HUM on 2025-07-07. The shares were previously bought for an average price of USD 263.605. The Humana Inc shares were sold for -10.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,537 The average price that the ETF previously sold HUM share for is USD 271.417 which is higher than the selling price of USD 237.21 on 2025-07-07. |
| DXCM - DexCom Inc | SELL | -434 @ USD 82.94 | USD -35,996 | The ETF sold 434 shares of DXCM on 2025-07-07. The shares were previously bought for an average price of USD 78.3581. The DexCom Inc shares were sold for 5.8% higher than average price of previous purchases. This sale made a profit of USD 1,989 The average price that the ETF previously sold DXCM share for is USD 77.0305 so the ETF has sold 434 shares on 2025-07-07 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -318 @ USD 119.25 | USD -37,922 | The ETF sold 318 shares of A on 2025-07-07. The shares were previously bought for an average price of USD 126.417. The Agilent Technologies Inc shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,279 The average price that the ETF previously sold A share for is USD 130.355 which is higher than the selling price of USD 119.25 on 2025-07-07. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -510 @ USD 74.61 | USD -38,051 | The ETF sold 510 shares of GEHC on 2025-07-07. The shares were previously bought for an average price of USD 82.0681. The GE HealthCare Technologies Inc. shares were sold for -9.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,804 The average price that the ETF previously sold GEHC share for is USD 79.8409 which is higher than the selling price of USD 74.61 on 2025-07-07. |
| RMD - ResMed Inc | SELL | -162 @ USD 256.41 | USD -41,538 | The ETF sold 162 shares of RMD on 2025-07-07. The shares were previously bought for an average price of USD 237.406. The ResMed Inc shares were sold for 8.0% higher than average price of previous purchases. This sale made a profit of USD 3,079 The average price that the ETF previously sold RMD share for is USD 242.014 so the ETF has sold 162 shares on 2025-07-07 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -264 @ USD 167.63 | USD -44,254 | The ETF sold 264 shares of CAH on 2025-07-07. The shares were previously bought for an average price of USD 132.76. The Cardinal Health Inc shares were sold for 26.3% higher than average price of previous purchases. This sale made a profit of USD 9,206 The average price that the ETF previously sold CAH share for is USD 129.643 so the ETF has sold 264 shares on 2025-07-07 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -88 @ USD 545.56 | USD -48,009 | The ETF sold 88 shares of IDXX on 2025-07-07. The shares were previously bought for an average price of USD 451.69. The IDEXX Laboratories Inc shares were sold for 20.8% higher than average price of previous purchases. This sale made a profit of USD 8,261 The average price that the ETF previously sold IDXX share for is USD 442.24 so the ETF has sold 88 shares on 2025-07-07 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -652 @ USD 76.69 | USD -50,002 | The ETF sold 652 shares of EW on 2025-07-07. The shares were previously bought for an average price of USD 71.5785. The Edwards Lifesciences Corp shares were sold for 7.1% higher than average price of previous purchases. This sale made a profit of USD 3,333 The average price that the ETF previously sold EW share for is USD 71.1035 so the ETF has sold 652 shares on 2025-07-07 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -318 @ USD 172.95 | USD -54,998 | The ETF sold 318 shares of BDX on 2025-07-07. The shares were previously bought for an average price of USD 219.065. The Becton Dickinson and Company shares were sold for -21.1% lower than average price of previous purchases. This resulted in an overall loss of USD 14,665 The average price that the ETF previously sold BDX share for is USD 215.534 which is higher than the selling price of USD 172.95 on 2025-07-07. |
| COR - Cencora Inc. | SELL | -190 @ USD 302.5 | USD -57,475 | The ETF sold 190 shares of COR on 2025-07-07. The shares were previously bought for an average price of USD 261.802. The Cencora Inc. shares were sold for 15.5% higher than average price of previous purchases. This sale made a profit of USD 7,733 The average price that the ETF previously sold COR share for is USD 252.965 so the ETF has sold 190 shares on 2025-07-07 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -116 @ USD 538.11 | USD -62,421 | The ETF sold 116 shares of REGN on 2025-07-07. The shares were previously bought for an average price of USD 679.66. The Regeneron Pharmaceuticals Inc shares were sold for -20.8% lower than average price of previous purchases. This resulted in an overall loss of USD 16,420 The average price that the ETF previously sold REGN share for is USD 709.602 which is higher than the selling price of USD 538.11 on 2025-07-07. |
| HCA - HCA Holdings Inc | SELL | -192 @ USD 378.98 | USD -72,764 | The ETF sold 192 shares of HCA on 2025-07-07. The shares were previously bought for an average price of USD 342.952. The HCA Holdings Inc shares were sold for 10.5% higher than average price of previous purchases. This sale made a profit of USD 6,917 The average price that the ETF previously sold HCA share for is USD 337.415 so the ETF has sold 192 shares on 2025-07-07 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -492 @ USD 157.05 | USD -77,269 | The ETF sold 492 shares of ZTS on 2025-07-07. The shares were previously bought for an average price of USD 166.363. The Zoetis Inc shares were sold for -5.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,582 The average price that the ETF previously sold ZTS share for is USD 169.796 which is higher than the selling price of USD 157.05 on 2025-07-07. |
| ELV - Elevance Health Inc | SELL | -250 @ USD 346.88 | USD -86,720 | The ETF sold 250 shares of ELV on 2025-07-07. The shares were previously bought for an average price of USD 405.601. The Elevance Health Inc shares were sold for -14.5% lower than average price of previous purchases. This resulted in an overall loss of USD 14,680 The average price that the ETF previously sold ELV share for is USD 397.341 which is higher than the selling price of USD 346.88 on 2025-07-07. |
| ELV - Elevance Health Inc | SELL | -250 @ USD 346.88 | USD -86,720 | The ETF sold 250 shares of ELV on 2025-07-07. The shares were previously bought for an average price of USD 405.601. The Elevance Health Inc shares were sold for -14.5% lower than average price of previous purchases. This resulted in an overall loss of USD 14,680 The average price that the ETF previously sold ELV share for is USD 397.341 which is higher than the selling price of USD 346.88 on 2025-07-07. |
| CI - Cigna Corp | SELL | -296 @ USD 313.63 | USD -92,834 | The ETF sold 296 shares of CI on 2025-07-07. The shares were previously bought for an average price of USD 316.282. The Cigna Corp shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 785 The average price that the ETF previously sold CI share for is USD 313.299 so the ETF has sold 296 shares on 2025-07-07 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -138 @ USD 735.33 | USD -101,476 | The ETF sold 138 shares of MCK on 2025-07-07. The shares were previously bought for an average price of USD 639.059. The McKesson Corporation shares were sold for 15.1% higher than average price of previous purchases. This sale made a profit of USD 13,285 The average price that the ETF previously sold MCK share for is USD 617.839 so the ETF has sold 138 shares on 2025-07-07 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -2,266 @ USD 46.49 | USD -105,346 | The ETF sold 2266 shares of BMY on 2025-07-07. The shares were previously bought for an average price of USD 55.4006. The Bloomsbury Publishing Plc shares were sold for -16.1% lower than average price of previous purchases. This resulted in an overall loss of USD 20,191 The average price that the ETF previously sold BMY share for is USD 55.1501 which is higher than the selling price of USD 46.49 on 2025-07-07. |
| MDT - Medtronic PLC | SELL | -1,428 @ USD 87.67 | USD -125,193 | The ETF sold 1428 shares of MDT on 2025-07-07. The shares were previously bought for an average price of USD 88.3291. The Medtronic PLC shares were sold for -0.7% lower than average price of previous purchases. This resulted in an overall loss of USD 941 The average price that the ETF previously sold MDT share for is USD 85.538 so the ETF has sold 1428 shares on 2025-07-07 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -284 @ USD 459.41 | USD -130,472 | The ETF sold 284 shares of VRTX on 2025-07-07. The shares were previously bought for an average price of USD 472.108. The Vertex Pharmaceuticals Inc shares were sold for -2.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,606 The average price that the ETF previously sold VRTX share for is USD 461.526 which is higher than the selling price of USD 459.41 on 2025-07-07. |
| DHR - Danaher Corporation | SELL | -708 @ USD 199.63 | USD -141,338 | The ETF sold 708 shares of DHR on 2025-07-07. The shares were previously bought for an average price of USD 213.818. The Danaher Corporation shares were sold for -6.6% lower than average price of previous purchases. This resulted in an overall loss of USD 10,045 The average price that the ETF previously sold DHR share for is USD 226.305 which is higher than the selling price of USD 199.63 on 2025-07-07. |
| DHR - Danaher Corporation | SELL | -708 @ USD 199.63 | USD -141,338 | The ETF sold 708 shares of DHR on 2025-07-07. The shares were previously bought for an average price of USD 213.818. The Danaher Corporation shares were sold for -6.6% lower than average price of previous purchases. This resulted in an overall loss of USD 10,045 The average price that the ETF previously sold DHR share for is USD 226.305 which is higher than the selling price of USD 199.63 on 2025-07-07. |
| SYK - Stryker Corporation | SELL | -382 @ USD 392.51 | USD -149,939 | The ETF sold 382 shares of SYK on 2025-07-07. The shares were previously bought for an average price of USD 378.931. The Stryker Corporation shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of USD 5,187 The average price that the ETF previously sold SYK share for is USD 376.384 so the ETF has sold 382 shares on 2025-07-07 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -1,384 @ USD 111.78 | USD -154,704 | The ETF sold 1384 shares of GILD on 2025-07-07. The shares were previously bought for an average price of USD 103.816. The Guild Esports Plc shares were sold for 7.7% higher than average price of previous purchases. This sale made a profit of USD 11,022 The average price that the ETF previously sold GILD share for is USD 96.4824 so the ETF has sold 1384 shares on 2025-07-07 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -6,332 @ USD 25.24 | USD -159,820 | The ETF sold 6332 shares of PFE on 2025-07-07. The shares were previously bought for an average price of USD 25.4721. The Pfizer Inc shares were sold for -0.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,470 The average price that the ETF previously sold PFE share for is USD 25.657 which is higher than the selling price of USD 25.24 on 2025-07-07. |
| BSX - Boston Scientific Corporation | SELL | -1,648 @ USD 103.83 | USD -171,112 | The ETF sold 1648 shares of BSX on 2025-07-07. The shares were previously bought for an average price of USD 99.2677. The Boston Scientific Corporation shares were sold for 4.6% higher than average price of previous purchases. This sale made a profit of USD 7,519 The average price that the ETF previously sold BSX share for is USD 92.4049 so the ETF has sold 1648 shares on 2025-07-07 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -1,648 @ USD 103.83 | USD -171,112 | The ETF sold 1648 shares of BSX on 2025-07-07. The shares were previously bought for an average price of USD 99.2677. The MULSTRXSSXIMETFP shares were sold for 4.6% higher than average price of previous purchases. This sale made a profit of USD 7,519 The average price that the ETF previously sold BSX share for is USD 92.4049 so the ETF has sold 1648 shares on 2025-07-07 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -598 @ USD 292.95 | USD -175,184 | The ETF sold 598 shares of AMGN on 2025-07-07. The shares were previously bought for an average price of USD 300.759. The Amgen Inc shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,670 The average price that the ETF previously sold AMGN share for is USD 287.974 so the ETF has sold 598 shares on 2025-07-07 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -420 @ USD 418.7 | USD -175,854 | The ETF sold 420 shares of TMO on 2025-07-07. The shares were previously bought for an average price of USD 504.88. The Time Out Group plc shares were sold for -17.1% lower than average price of previous purchases. This resulted in an overall loss of USD 36,196 The average price that the ETF previously sold TMO share for is USD 501.143 which is higher than the selling price of USD 418.7 on 2025-07-07. |
| ISRG - Intuitive Surgical Inc | SELL | -398 @ USD 534.71 | USD -212,815 | The ETF sold 398 shares of ISRG on 2025-07-07. The shares were previously bought for an average price of USD 535.412. The Intuitive Surgical Inc shares were sold for -0.1% lower than average price of previous purchases. This resulted in an overall loss of USD 279 The average price that the ETF previously sold ISRG share for is USD 530.157 so the ETF has sold 398 shares on 2025-07-07 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -2,794 @ USD 80.9 | USD -226,035 | The ETF sold 2794 shares of MRK on 2025-07-07. The shares were previously bought for an average price of USD 90.1354. The Marks Electrical Group PLC shares were sold for -10.2% lower than average price of previous purchases. This resulted in an overall loss of USD 25,804 The average price that the ETF previously sold MRK share for is USD 95.629 which is higher than the selling price of USD 80.9 on 2025-07-07. |
| MRK - Merck & Company Inc | SELL | -2,794 @ USD 80.9 | USD -226,035 | The ETF sold 2794 shares of MRK on 2025-07-07. The shares were previously bought for an average price of USD 90.1354. The Merck & Company Inc shares were sold for -10.2% lower than average price of previous purchases. This resulted in an overall loss of USD 25,804 The average price that the ETF previously sold MRK share for is USD 95.629 which is higher than the selling price of USD 80.9 on 2025-07-07. |
| ABT - Abbott Laboratories | SELL | -1,938 @ USD 133.7 | USD -259,111 | The ETF sold 1938 shares of ABT on 2025-07-07. The shares were previously bought for an average price of USD 128.101. The Abbott Laboratories shares were sold for 4.4% higher than average price of previous purchases. This sale made a profit of USD 10,851 The average price that the ETF previously sold ABT share for is USD 120.545 so the ETF has sold 1938 shares on 2025-07-07 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -1,006 @ USD 303.71 | USD -305,532 | The ETF sold 1006 shares of UNH on 2025-07-07. The shares were previously bought for an average price of USD 495.756. The UnitedHealth Group Incorporated shares were sold for -38.7% lower than average price of previous purchases. This resulted in an overall loss of USD 193,198 The average price that the ETF previously sold UNH share for is USD 512.005 which is higher than the selling price of USD 303.71 on 2025-07-07. |
| ABBV - AbbVie Inc | SELL | -1,956 @ USD 187.63 | USD -367,004 | The ETF sold 1956 shares of ABBV on 2025-07-07. The shares were previously bought for an average price of USD 192.168. The AbbVie Inc shares were sold for -2.4% lower than average price of previous purchases. This resulted in an overall loss of USD 8,876 The average price that the ETF previously sold ABBV share for is USD 185.279 so the ETF has sold 1956 shares on 2025-07-07 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -2,662 @ USD 155.27 | USD -413,329 | The ETF sold 2662 shares of JNJ on 2025-07-07. The shares were previously bought for an average price of USD 156.97. The Johnson & Johnson shares were sold for -1.1% lower than average price of previous purchases. This resulted in an overall loss of USD 4,525 The average price that the ETF previously sold JNJ share for is USD 152.673 so the ETF has sold 2662 shares on 2025-07-07 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -864 @ USD 772.87 | USD -667,760 | The ETF sold 864 shares of LLY on 2025-07-07. The shares were previously bought for an average price of USD 829.133. The Eli Lilly and Company shares were sold for -6.8% lower than average price of previous purchases. This resulted in an overall loss of USD 48,611 The average price that the ETF previously sold LLY share for is USD 792.043 which is higher than the selling price of USD 772.87 on 2025-07-07. |